525 related articles for article (PubMed ID: 29632010)
1. Polymyxin B in Combination with Enrofloxacin Exerts Synergistic Killing against Extensively Drug-Resistant Pseudomonas aeruginosa.
Lin YW; Yu HH; Zhao J; Han ML; Zhu Y; Akter J; Wickremasinghe H; Walpola H; Wirth V; Rao GG; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632010
[TBL] [Abstract][Full Text] [Related]
2. From Breast Cancer to Antimicrobial: Combating Extremely Resistant Gram-Negative "Superbugs" Using Novel Combinations of Polymyxin B with Selective Estrogen Receptor Modulators.
Hussein MH; Schneider EK; Elliott AG; Han M; Reyes-Ortega F; Morris F; Blastovich MAT; Jasim R; Currie B; Mayo M; Baker M; Cooper MA; Li J; Velkov T
Microb Drug Resist; 2017 Jul; 23(5):640-650. PubMed ID: 27935770
[TBL] [Abstract][Full Text] [Related]
3. Novel Polymyxin Combination with the Antiretroviral Zidovudine Exerts Synergistic Killing against NDM-Producing Multidrug-Resistant Klebsiella pneumoniae.
Lin YW; Abdul Rahim N; Zhao J; Han ML; Yu HH; Wickremasinghe H; Chen K; Wang J; Paterson DL; Zhu Y; Rao GG; Zhou QT; Forrest A; Velkov T; Li J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30670431
[TBL] [Abstract][Full Text] [Related]
4. In Vitro Activity of Polymyxin B in Combination with Various Antibiotics against Extensively Drug-Resistant Enterobacter cloacae with Decreased Susceptibility to Polymyxin B.
Cai Y; Lim TP; Teo J; Sasikala S; Lee W; Hong Y; Chan EC; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
Antimicrob Agents Chemother; 2016 Sep; 60(9):5238-46. PubMed ID: 27324776
[TBL] [Abstract][Full Text] [Related]
5. Clinically relevant concentrations of fosfomycin combined with polymyxin B, tobramycin or ciprofloxacin enhance bacterial killing of Pseudomonas aeruginosa, but do not suppress the emergence of fosfomycin resistance.
Walsh CC; Landersdorfer CB; McIntosh MP; Peleg AY; Hirsch EB; Kirkpatrick CM; Bergen PJ
J Antimicrob Chemother; 2016 Aug; 71(8):2218-29. PubMed ID: 27118778
[TBL] [Abstract][Full Text] [Related]
6. An "Unlikely" Pair: The Antimicrobial Synergy of Polymyxin B in Combination with the Cystic Fibrosis Transmembrane Conductance Regulator Drugs KALYDECO and ORKAMBI.
Schneider EK; Azad MA; Han ML; Tony Zhou Q; Wang J; Huang JX; Cooper MA; Doi Y; Baker MA; Bergen PJ; Muller MT; Li J; Velkov T
ACS Infect Dis; 2016 Jul; 2(7):478-88. PubMed ID: 27626100
[TBL] [Abstract][Full Text] [Related]
7. Synergistic Combination of Polymyxin B and Enrofloxacin Induced Metabolic Perturbations in Extensive Drug-Resistant
Lin YW; Han ML; Zhao J; Zhu Y; Rao G; Forrest A; Song J; Kaye KS; Hertzog P; Purcell A; Creek D; Zhou QT; Velkov T; Li J
Front Pharmacol; 2019; 10():1146. PubMed ID: 31632279
[TBL] [Abstract][Full Text] [Related]
8. Polymyxin Combinations Combat
Bulman ZP; Chen L; Walsh TJ; Satlin MJ; Qian Y; Bulitta JB; Peloquin CA; Holden PN; Nation RL; Li J; Kreiswirth BN; Tsuji BT
mBio; 2017 Jul; 8(4):. PubMed ID: 28743810
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics Study of the Synergistic Killing of Polymyxin B in Combination with Amikacin against Polymyxin-Susceptible and -Resistant Pseudomonas aeruginosa.
Hussein M; Han ML; Zhu Y; Zhou Q; Lin YW; Hancock REW; Hoyer D; Creek DJ; Li J; Velkov T
Antimicrob Agents Chemother; 2019 Dec; 64(1):. PubMed ID: 31611351
[TBL] [Abstract][Full Text] [Related]
10. Evaluating Polymyxin B-Based Combinations against Carbapenem-Resistant Escherichia coli in Time-Kill Studies and in a Hollow-Fiber Infection Model.
Cai Y; Lim TP; Teo JQ; Sasikala S; Chan EC; Hong YJ; Lee W; Tan TY; Tan TT; Koh TH; Hsu LY; Kwa AL
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27795375
[TBL] [Abstract][Full Text] [Related]
11. Colistin plus meropenem combination is synergistic in vitro against extensively drug-resistant Pseudomonas aeruginosa, including high-risk clones.
Montero MM; Domene Ochoa S; López-Causapé C; VanScoy B; Luque S; Sorlí L; Campillo N; Padilla E; Prim N; Segura C; Pomar V; Rivera A; Grau S; Ambrose PG; Oliver A; Horcajada JP
J Glob Antimicrob Resist; 2019 Sep; 18():37-44. PubMed ID: 31154007
[TBL] [Abstract][Full Text] [Related]
12.
Chen H; Li H; Liu Z; Li J
Microb Drug Resist; 2020 Sep; 26(9):1108-1119. PubMed ID: 32349617
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin B in combination with doripenem against heteroresistant Acinetobacter baumannii: pharmacodynamics of new dosing strategies.
Rao GG; Ly NS; Bulitta JB; Soon RL; San Roman MD; Holden PN; Landersdorfer CB; Nation RL; Li J; Forrest A; Tsuji BT
J Antimicrob Chemother; 2016 Nov; 71(11):3148-3156. PubMed ID: 27494922
[TBL] [Abstract][Full Text] [Related]
14. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa.
Tam VH; Schilling AN; Vo G; Kabbara S; Kwa AL; Wiederhold NP; Lewis RE
Antimicrob Agents Chemother; 2005 Sep; 49(9):3624-30. PubMed ID: 16127031
[TBL] [Abstract][Full Text] [Related]
15. Meropenem Combined with Ciprofloxacin Combats Hypermutable Pseudomonas aeruginosa from Respiratory Infections of Cystic Fibrosis Patients.
Rees VE; Yadav R; Rogers KE; Bulitta JB; Wirth V; Oliver A; Boyce JD; Peleg AY; Nation RL; Landersdorfer CB
Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30104278
[TBL] [Abstract][Full Text] [Related]
16. Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.
Tsuji BT; Landersdorfer CB; Lenhard JR; Cheah SE; Thamlikitkul V; Rao GG; Holden PN; Forrest A; Bulitta JB; Nation RL; Li J
Antimicrob Agents Chemother; 2016 Jul; 60(7):3913-20. PubMed ID: 27067330
[TBL] [Abstract][Full Text] [Related]
17. Assessment of polymyxin B-doxycycline in combination against Pseudomonas aeruginosa in vitro and in a mouse model of acute pneumonia.
Gaurav A; Kothari A; Omar BJ; Pathania R
Int J Antimicrob Agents; 2020 Jul; 56(1):106022. PubMed ID: 32439481
[TBL] [Abstract][Full Text] [Related]
18. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
Ardebili A; Izanloo A; Rastegar M
Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
[TBL] [Abstract][Full Text] [Related]
19. Optimization of Polymyxin B in Combination with Doripenem To Combat Mutator Pseudomonas aeruginosa.
Ly NS; Bulman ZP; Bulitta JB; Baron C; Rao GG; Holden PN; Li J; Sutton MD; Tsuji BT
Antimicrob Agents Chemother; 2016 May; 60(5):2870-80. PubMed ID: 26926641
[TBL] [Abstract][Full Text] [Related]
20. Synergistic combinations of polymyxins.
Lenhard JR; Nation RL; Tsuji BT
Int J Antimicrob Agents; 2016 Dec; 48(6):607-613. PubMed ID: 27865626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
